A carregar...
Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients
Baricitinib is an oral Janus kinase (JAK)1/JAK2 inhibitor approved for the treatment of rheumatoid arthritis (RA) that was independently predicted, using artificial intelligence (AI) algorithms, to be useful for COVID‐19 infection via proposed anti‐cytokine effects and as an inhibitor of host cell v...
Na minha lista:
| Publicado no: | EMBO Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7300657/ https://ncbi.nlm.nih.gov/pubmed/32473600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202012697 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|